Dr. Paul Hyoun Kim, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 23600 Telo Ave, 130, Torrance, CA 90505 Phone: 310-530-1010 Fax: 310-530-1031 |
Richard H Goldin, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 23441 Madison St, Suite #340, Torrance, CA 90505 Phone: 310-373-0340 Fax: 310-373-7142 |
George Karpouzas, M.D. Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 21840 Normandie Ave, Ste. 700, Torrance, CA 90502 Phone: 310-222-5101 Fax: 310-320-5463 |
Maryann Kimoto, D.O. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3500 Lomita Blvd Ste M100, Torrance, CA 90505 Phone: 310-517-8578 Fax: 310-517-8588 |
Dr. David Jordan Klashman, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 23441 Madison St, Suite #340, Torrance, CA 90505 Phone: 310-373-0340 Fax: 310-373-7142 |
Dilrukshie Cooray, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 21840 Normandie Ave, Ste. 700, Torrance, CA 90502 Phone: 310-222-5101 Fax: 310-320-5463 |
Dr. David D Oh, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 21350 Hawthorne Blvd Ste 260, Torrance, CA 90503 Phone: 310-543-2977 Fax: 310-543-3147 |
Michael R. Liebling, M.D. Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 21840 Normandie Ave, Ste. 700, Torrance, CA 90502 Phone: 310-222-5101 Fax: 310-320-5463 |
Viet Lac Bui, MD, PHD Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 1000 W Carson St # 470, Torrance, CA 90502 Phone: 310-222-3697 Fax: 310-782-0595 |
Dr. John Paul Hoying, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3565 Del Amo Blvd, Torrance, CA 90503 Phone: 310-214-0811 Fax: 310-370-2751 |
Sheherbano Mehdi, M.D Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 23441 Madison St, Suite #340, Torrance, CA 90505 Phone: 310-373-0340 |
Kenneth M Nies, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 23441 Madison St, Suite #340, Torrance, CA 90505 Phone: 310-373-0340 Fax: 310-373-7142 |
Dr. Michael Drew Duffin, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3565 Del Amo Blvd, Torrance, CA 90503 Phone: 310-214-0811 Fax: 310-793-4679 |
Dr. Joe Gamboa, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 23326 Hawthorne Blvd, Suite 200, Torrance, CA 90505 Phone: 310-257-7205 Fax: 310-598-3119 |
William Chin, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 19191 S Vermont Ave, S-200, Torrance, CA 90502 Phone: 310-354-4209 Fax: 310-538-0671 |
Dr. Bett Eng, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 23441 Madison St, Suite #340, Torrance, CA 90505 Phone: 310-373-0340 Fax: 310-373-7142 |
News Archive
Blood pressure and stroke risk increase steadily with increasing alcohol intake, and previous claims that 1-2 alcoholic drinks a day might protect against stroke are dismissed by new evidence from a genetic study involving 160,000 adults.
Though many people suffering from neurological conditions such as cerebral palsy and Lou Gehrig's disease have lost their ability to speak, they can communicate using augmentative and alternative communications (AAC) devices such as keyboards, head sticks, and other hands-free options.
Ligand Pharmaceuticals Incorporated has amended its license agreement with Exelixis, Inc. as a result of which Ligand is now entitled to receive royalties on net sales of future products from a mineralocorticoid receptor program and a one-time $75,000 payment for providing access to certain patent rights.
Octapharma AG today announced the start of the first of a series of Phase III studies for its new 10% high purity intravenous immunoglobulin (IVIG). The study will investigate the efficacy and safety of this novel immunoglobulin in the treatment of primary immune deficiency and, together with results from additional upcoming studies, will support its regulatory filing in Europe and the US.
› Verified 9 days ago